5713 Recruiting Trials

Clinical Trials in California

Browse 5713 recruiting clinical trials currently enrolling participants in California. Search by condition to find trials you may qualify for — at no cost.

Showing 15 of 5713 recruiting trials in California

TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
PHASE2 Birmingham, Alabama +4 sites · Multiple Myeloma, Advanced Solid Tumors
Recruiting
Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change
PHASE2 Anchorage, Alaska +4 sites · Advanced Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma
Recruiting
Characterization and Treatment of Adolescent Depression
N/A Los Angeles, California +2 sites · Depression
Recruiting
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
PHASE2 Birmingham, Alabama +4 sites · Sarcomatoid Renal Cell Carcinoma, Stage IV Renal Cell Cancer AJCC v8
Recruiting
Real-world Experience of Catheter Ablation for the Treatment of Arrhythmias
N/A Birmingham, Alabama +4 sites · Paroxysmal Atrial Fibrillation, Persistent Atrial Fibrillation
Recruiting
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
PHASE3 Anchorage, Alaska +4 sites · Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8
Recruiting
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
PHASE3 Birmingham, Alabama +4 sites · Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Recruiting
UCSF PANC Cyst Registry
N/A San Francisco, California · Pancreatic Cancer, Pancreatic Neoplasms
Recruiting
Hydrus® Microstent New Enrollment Post-Approval Study
NA Irvine, California +4 sites · Primary Open Angle Glaucoma
Recruiting
Brentuximab Vedotin and Nivolumab for the Treatment of Patients With Relapsed/Refractory Classical Hodgkin Lymphoma
PHASE2 Duarte, California +4 sites · Relapsed Classic Hodgkin Lymphoma
Recruiting
Trastuzumab Deruxtecan (DS-8201a) for the Treatment of Recurrent or Refractory Osteosarcoma, Wilms Tumor, and Desmoplastic Small Round Cell Tumor
PHASE2 Birmingham, Alabama +4 sites · Wilms Tumor, Osteosarcoma
Recruiting
Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma
PHASE2 Birmingham, Alabama +4 sites · Recurrent Head and Neck Squamous Cell Carcinoma, Recurrent Hypopharyngeal Squamous Cell Carcinoma
Recruiting
Precision-Based Genomics in Prostate Cancer
N/A La Jolla, California +4 sites · Prostate Cancer
Recruiting
A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
PHASE3 San Francisco, California +4 sites · Crohn's Disease, Inflammatory Bowel Diseases
Recruiting
Study of Lunresertib Alone or in Combination With RP-3500 or Debio 0123 in Patients With Advanced Solid Tumors
PHASE1 Los Angeles, California +4 sites · Advanced Solid Tumor
Recruiting
See all 5713 results in California

Check Your Eligibility

Create a free profile and our AI will match you to trials in California you may qualify for.

Get Matched — Free
No insurance required
Search by Condition in California
Diabetes Cancer Breast Cancer Depression Anxiety Alzheimer's Heart Disease Asthma Multiple Sclerosis Obesity Parkinson's Lupus Hypertension COPD Stroke Arthritis Kidney Disease COVID-19
Browse Other States
California Texas New York Florida Illinois Pennsylvania Ohio Georgia North Carolina Michigan New Jersey Washington Arizona Massachusetts Tennessee Colorado Minnesota Maryland Wisconsin Oregon